Live from the NIH registry
Studies recruiting near Gainesville right now
Top 25 of 149 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
Iron Deficiency Anemia
Phase 3
Interventional 75 participants sought
Gwinnett Research Institute — Buford, Georgia (15.4 mi)
· Sponsor: AMAG Pharmaceuticals, Inc.
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
Angiokeratomas
Phase 2
Interventional 15 participants sought
Cleaver Medical Group — Dawsonville, Georgia (18.8 mi)
· Sponsor: Palvella Therapeutics, Inc.
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
Parris and Associates Rheumatology — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
Uncontrolled Hypertension
Phase 2
Interventional 280 participants sought
Retension Clinical Site — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Retension Pharmaceuticals. Inc.
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Brain Cancer, Breast Cancer
N/A
Observational 7,000 participants sought
North Georgia Health System — Gainesville, Georgia (0.6 mi)
· Sponsor: Adela, Inc
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Phase 2
Interventional 630 participants sought
Research Site — Gainesville, Georgia (0.6 mi)
· Sponsor: AstraZeneca
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 180 participants sought
Cleaver Medical Group Dermatology, Inc — Cumming, Georgia (18.7 mi)
· Sponsor: Organon and Co
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
Keratoconus, Ectasia of Cornea
Phase 3
Interventional 485 participants sought
Woolfson Eye Institute — Cumming, Georgia (18.7 mi)
· Sponsor: Woolfson Eye Institute
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Cleaver Medical Group — Cumming, Georgia (18.7 mi)
· Sponsor: Incyte Corporation
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
Staphylococcus Aureus
Phase 1, Phase 2
Interventional 231 participants sought
Research Site — Lawrenceville, Georgia (24.8 mi)
· Sponsor: AstraZeneca
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Physicians Research Associates LLC — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Zucara Therapeutics Inc.
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
Down Syndrome (DS), Keratoconus
Phase 3
Interventional 225 participants sought
Woolfson Eye Institute — Cumming, Georgia (18.7 mi)
· Sponsor: Woolfson Eye Institute
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Phase 2, Phase 3
Interventional 176 participants sought
Georgia Nephrology — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
Systemic Lupus Erythematosus
Phase 4
Interventional 350 participants sought
GSK Investigational Site — Sugar Hill, Georgia (17.2 mi)
· Sponsor: GlaxoSmithKline
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
Northside Hospital - Gwinnett — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Wake Forest University Health Sciences
Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure
Heart Failure
N/A
Interventional 4,000 participants sought
Emory Johns Creek Hospital — Johns Creek, Georgia (27.8 mi)
· Sponsor: Emory University
Study of BHV-1400 in IgA Nephropathy
IgA Nephropathy
Phase 1
Interventional 20 participants sought
Site-008 — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Emory Johns Creek Hospital — Johns Creek, Georgia (27.8 mi)
· Sponsor: Canadian Cancer Trials Group
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Northside Hospital-Forsyth — Cumming, Georgia (18.7 mi)
· Sponsor: NRG Oncology
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 144 participants sought
Cleaver Medical Group Dermatology- Site Number : 8400008 — Cumming, Georgia (18.7 mi)
· Sponsor: Sanofi
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Gainesville, Georgia (0.6 mi)
· Sponsor: Akero Therapeutics, Inc
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
Phase 3
Interventional 2,000 participants sought
Research Site — Gainesville, Georgia (0.6 mi)
· Sponsor: DalCor Pharmaceuticals
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
Glomerulonephritis, IGA, Immunoglobulin A Nephropathy
Phase 2
Interventional 20 participants sought
Georgia Nephrology Research Inst — Lawrenceville, Georgia (24.8 mi)
· Sponsor: Novartis Pharmaceuticals
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain
Phase 3
Interventional 200 participants sought
Northside Hospital-Forsyth — Cumming, Georgia (18.7 mi)
· Sponsor: NRG Oncology
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
APOL1-Mediated Kidney Disease
Phase 2
Interventional 136 participants sought
Research Site — Lawrenceville, Georgia (24.8 mi)
· Sponsor: AstraZeneca